Showing results (161-170 of 171) with videos related to

Sort By:
Pageof 18
Esophagus : Official Journal of the Japan Esophageal Society|November 25, 2025
Feasibility of endoscopic response evaluation after induction chemotherapy for determining treatment strategies in esophageal cancer: a post hoc analysis of the CROC trialChikatoshi Katada, Tetsuji Yokoyama, Akinori Watanabe, et al.
Stem Cell Reports|February 25, 2016
Functional Neurons Generated from T Cell-Derived Induced Pluripotent Stem Cells for Neurological Disease ModelingTakuya Matsumoto, Koki Fujimori, Tomoko Andoh-Noda, et al.
International Journal of Radiation Oncology, Biology, Physics|July 5, 2024
Optimizing Organ-Preservation Strategies Through Chemotherapy-Based Selection in Esophageal Squamous Cell Carcinoma: Results From the CROC Multi-Institutional Phase 2 Clinical TrialChikatoshi Katada, Tetsuji Yokoyama, Akinori Watanabe, et al.
The Oncologist|February 18, 2026
Novel antiemetic effect of naldemedine in patients initiating opioids for cancer pain: A secondary analysis of a randomized clinical trialTakahiro Higashibata, Takaomi Kessoku, Shinya Kajiura, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|December 31, 2024
Prevalence and clinicopathological features of microsatellite instability-high metastatic or recurrent gastric and esophagogastric junction cancer: WJOG13320GPSAzusa Komori, Shuichi Hironaka, Shigenori Kadowaki, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 16, 2022
Multicenter, prospective, observational study of chemotherapy-induced dysgeusia in gastrointestinal cancerKen Ito, Satoshi Yuki, Hiroshi Nakatsumi, et al.
Gut|April 16, 2025
Precision risk stratification of primary gastric cancer after eradication of <i>H. pylori</i> by a DNA methylation marker: a multicentre prospective studyHarumi Yamada, Seiichiro Abe, Hadrien Charvat, et al.
Frontiers in Oncology|November 28, 2022
Study protocol for HGCSG1801: A multicenter, prospective, phase II trial of second-line FOLFIRI plus aflibercept in patients with metastatic colorectal cancer refractory to anti-EGFR antibodiesHiroshi Nakatsumi, Yoshito Komatsu, Tetsuhito Muranaka, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2024
Naldemedine for Opioid-Induced Constipation in Patients With Cancer: A Multicenter, Double-Blind, Randomized, Placebo-Controlled TrialJun Hamano, Takahiro Higashibata, Takaomi Kessoku, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|November 1, 2022
Pattern of disease progression during third-line or later chemotherapy with nivolumab associated with poor prognosis in advanced gastric cancer: a multicenter retrospective study in JapanMasahiko Aoki, Shigenori Kadowaki, Naoki Takahashi, et al.
Pageof 18